LivaNova Plc (LIVN)

Add to research

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Company performance
Add to research
View more

Current Price

as of Jun 20, 2025

$45.51

P/E Ratio

N/A

Market Cap

$2.48B

Description
Add to research
View more

LivaNova Plc is a global medical technology company, which engages in the development and delivery of therapeutic solutions for the benefit of patients, healthcare professionals, and healthcare systems. It operates through the following segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support (ACS). The Cardiopulmonary segment is involved in the design, development, manufacture, marketing and selling of cardiopulmonary products. The Neuromodulation segment is associated in the design, development, manufacture, marketing and selling of devices that deliver neuromodulation therapy for treating DRE and DTD. The ACS segment deals with the design, development, manufacture, marketing and selling of temporary life support products. The company was founded in 1987 and is headquartered in London, the United Kingdom.

Metrics
Add to research
View more

Overview

  • HQLondon, GL
  • SectorHealth Technology
  • IndustryMedical Specialties
  • TickerLIVN
  • Price$45.51+0.75%

Trading Information

  • Market cap$2.48B
  • Float99.58%
  • Average Daily Volume (1m)639,619
  • Average Daily Volume (3m)778,022
  • EPS-$4.08

Company

  • Revenue$1.28B
  • Rev growth (1yr)8.84%
  • Net income-$327.32M
  • Gross margin69.68%
  • EBITDA margin-93.57%
  • EBITDA-$296.49M
  • EV$2.08B
  • EV/Revenue1.63
  • P/EN/A
  • P/S1.94
  • P/B2.40
  • Debt/Equity65.54
Documents
Add to research
View more